Physician profile
Nathan Degn
NPI 1619498375
$381.62
in general payments reported to CMS, 2019-2025
8 companies · $69.10 in 2025
The $69.10 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.52 · 2021: $19.17 · 2022: $12.32 · 2023: $18.39 · 2024: $247 · 2025: $69.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $124.58 | 2024 | Xiidra, Miebo |
| Abbvie INC. | $82.18 | 2024-2025 | |
| Amgen INC. | $79.59 | 2024-2025 | Tepezza |
| Biotissue Holdings INC. | $26.58 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $19.17 | 2021 | |
| Horizon Therapeutics Plc | $18.39 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $15.61 | 2025 | Xdemvy |
| Alcon Vision LLC | $15.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Degn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.